4 ms·

We are. Many avenues are being explored by different teams. https://www.jsonline.com/story/news/2020/04/03/promising-use-plasma-coronavirus-survivors-reaches-t

• AnotherGoodName 7y ago
  Yeah the real confusion for me is why even bother looking at anything other than these actual existing SAR-2 antibodies. "Hey these SARS-1 antibodies 'almost' work" Meanwhile there's literally a ton of antibodies out there that work well.
  • biophetik 7y ago
    One of the main reasons (most likely) is that these antibodies are already purified and in stock in the laboratories. So I'd be relatively easy to start researching the binding sites to SARS-COV-2. And since there is a relationship between the 2 viruses you can get useful information even if it's not perfect.